Cite
HARVARD Citation
Schnyder, J. et al. (n.d.). SAT0143 A PHASE 1 STUDY IN HEALTHY VOLUNTEERS EXPLORING THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ATI-450: A NOVEL ORAL MK2 INHIBITOR. Annals of the rheumatic diseases. p. 1010. [Online].